Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 33, pseudogene (RNU6-33P)** is a pseudogene derived from the U6 small nuclear RNA gene family. It is located on human chromosome 4 (chr4: 88,684,848-88,684,954, reverse strand), but as a pseudogene, it is not considered functional and does not encode a protein or functional RNA product[2][3][6][8][9]. RNU6-33P is annotated as a non-coding, small nuclear RNA pseudogene, reflecting its similarity to functional U6 snRNA genes, which are core components of spliceosomal ribonucleoproteins involved in mRNA splicing[1]. However, RNU6-33P itself has no known biological function, is not implicated in any disease, does not interact with drugs, and is not a therapeutic target. This entry may be incorrect as a drug target because pseudogenes generally do not produce active molecular products and lack therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 33, pseudogene (RNU6-33P).